Order Entry
Northern Ireland
ContactUsLinkComponent
Human recombinant serpin E2 (from HEK293 cells)
Human recombinant serpin E2 (from HEK293 cells)
Catalog # PRSI96-683
Supplier:  ProSci Inc.
CAS Number:  
undefined
Human recombinant serpin E2 (from HEK293 cells)
Catalog # PRSI96-683
Supplier:  ProSci Inc.
CAS Number:  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

Specifications

  • Pk:
    25 µG
  • Protein/peptide type:
    Recombinant
  • Source:
    HEK293 cells
  • Species:
    Human
  • Biological activity:
    Measured by its ability to inhibit trypsin cleavage of a fluorogenic peptide substrate, Mca - RPKPVE - Nval - WRK(Dnp) - NH2.
  • Protein synonyms:
    Glia-derived nexin|PI7|SERPINE2|GDN|SerpinE2|Peptidase inhibitor 7|PN-1|Serpin E2|PI-7|Protease nexin 1
  • Protein/peptide name:
    Serpin E2
  • Purity:
    >92% as determined by SDS-PAGE.
  • Molecular weight:
    42.7 kDa
  • Formulation:
    Lyophilized, 20 mM NaAc, 100 mM NaCl, PH6.5
  • Tested applications:
    Western Blot

Specifications

About this item

SERPINE2 is also known as Glia-derived nexin (GDN), Peptidase inhibitor 7 (PI7), Protease nexin 1(PN1). SERPINE2 is a secreted glycoprotein which belongs to the serpin family. SerpinE1 is the primary physiological inhibitor of the two plasminogen activators urokinase (uPA) and tissue plasminogen activator (tPA). PAI-1 / GDN is also implicated in adipose tissue development. It suggests that PAI-1 inhibitors serve in the control of atherothrombosis. Defects in Serpin E1 / PN1 are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency) which is characterized by abnormal bleeding due to SerpinE1 defect in the plasma.